CARDIOPROGRESS
Foundation for the advancement of cardiology

Risk of rehospitalization in younger women after heart attack nearly double that of men Women aged 55 years and younger have nearly double the risk of rehospitalization in the year immediately after a heart attack compared to men of similar age, according to a study supported by the National Institutes of Health.

Cancer and heart disease services put at risk by coronavirus response UK Biobank study suggests heart scans could help identify early damage and guide post-treatment care.

Recognizing efforts to reduce the burden of cardiovascular and kidney disease in type 2 diabetes Type 2 diabetes is one of the leading causes of premature cardiovascular death and significantly contributes to cardiovascular morbidity and kidney disease.

Statin Primary Prevention Trial in HIV Halted for Efficacy An international clinical trial testing statin therapy for primary cardiovascular prevention in people living with HIV has been stopped early due to strong evidence of efficacy and safety in this population.

Heart Disease Risk May Start Before Birth A woman's prepregnancy heart health is critical to both her health as well as the health of the children she gives birth to, according to researchers.

Cancer survivors may be at heightened risk of cardiovascular disease An international clinical trial testing statin therapy for primary cardiovascular prevention in people living with HIV has been stopped early due to strong evidence of efficacy and safety in this population.

High Biomarker Level Plus Diabetes Predict Bad PCI Outcomes Among patients with type 2 diabetes and coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI), those with a high platelet-to-lymphocyte ratio (PLR) at the time of their procedure had a significantly higher risk for major adverse cardiovascular and cerebrovascular events (MACCE) and stent thrombosis compared with similar patients with a low PLR during a median 2.4-year follow-up. Patients with PCI and a high PLR, but without type 2 diabetes, were not at increased risk for these outcomes compared with similar patients with a low PLR.

Dabigatran Recalled Over Potential Carcinogen Ascend Laboratories LLC is recalling 10 lots of the oral anticoagulant dabigatran etexilate capsules (75 mg and 150 mg) because of unacceptable levels of a potential carcinogen.

Treat to LDL Target or High-Intensity Statin for All With Clinical CAD: LODESTAR How secondary prevention statins are given to push LDL cholesterol levels lower, whether in a high-intensity statin regimen or by dosage titration to meet LDL targets, may make little difference to clinical outcomes, suggests a randomized trial.

Sports-Related Sudden Cardiac Arrest 'Extremely' Rare in Women Sports-related sudden cardiac arrest (Sr-SCA) appears to be extremely rare in women compared with men, despite similar characteristics and circumstances of occurrence, data from three European population-based registries suggest.

The New Playbook for Ditching Dangerous Senior Meds A new tool presented at the American Geriatrics Society (AGS) 2025 Annual Scientific Meeting may give clinicians practical and safer alternatives to risky medications for patients.

International Research in Cardiology 2010-2014 Dear colleagues!
The Cardioprogress Foundation presents the book «International Research in Cardiology», which includes the results of the most important international clinical trials presented in 2010-2024. The authors systematized studies in 21 sections, which include risk factors, antiplatelet and anticoagulant therapy, laboratory and instrumental diagnostics, arrhythmia, invasive cardiology, valvular heart diseases, intensive care in cardiology and more.

American Heart Associated A new statement from the American College of Cardiology (ACC) is calling for a greater degree of career flexibility in the specialty to promote cardiologists' personal and professional well-being and preserve excellence in patient care.

American Heart Associations conference

Prof. Aronow's career path Dear colleagues! The Cardioprogress Foundation presents the excerpts from the memoirs of the International Journal of Heart and Vascular Diseases editorial board member Wilbert S. Aronov, a cardiologist, professor of medicine, member of the FACC, FAHA, FACP, FCCP, FASPC, AGSF, FGSA. Dr. Wilbert Solomon Aronow was born in New York City on October 30, 1931. His parents were Russian Jewish immigrants. His grandparents were rabbis in Russia. Doctor Aronov dedicated his professional career to medicine.

World Heart Day 2022 in Iloilo Iloilo province made history for hosting this year’s World Heart Day. It was chosen by the World Health Organization (WHO) as pilot area for the celebration. As highlight of the event, the whole façade of the Iloilo provincial capitol was illuminated on Thursday night, Sept. 29. The ceremonial event was led by Gov. Arthur Defensor Jr.; Department of Health (DOH) undersecretaries Dr. Kenneth Ronquillo and Atty. Charade Grande; DOH Western Visayas regional director, Dr. Adriano Zubaan; and representatives from WHO, Resolve to Save Lives, and World Heart Federation.

Climate change and health inequity a deadly mix for the most vulnerable: World Heart Federation Geneva, 29 September 2022 - On World Heart Day, the World Heart Federation (WHF) is calling for urgent action on climate change and health inequity, with millions more lives now at risk from cardiovascular disease, which is still the world’s biggest killer.

New ESC Guidelines for Cutting CV Risk in Noncardiac Surgery The European Society of Cardiology (ESC) guidelines on cardiovascular assessment and management of patients undergoing noncardiac surgery have seen extensive revision since the 2014 version. They still have the same aim — to prevent surgery-related bleeding complications, perioperative myocardial infarction/injury (PMI), stent thrombosis, acute heart failure, arrhythmias, pulmonary embolism, ischemic stroke, and cardiovascular (CV) death.

CONFERENCE NEWS

U.S. declares monkeypox public health emergency Following growing pressure to ramp up response efforts against monkeypox, the U.S. declared a public health emergency. There are around 6,600 infections nationwide, reaching all but two states. The White House plans to roll out several million doses of monkeypox vaccines and are targeting at-risk communities.